MARKET WIRE NEWS

Pluri Inc. (NASDAQ : PLUR ) Stock

Share:

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pluristem Therapeutics Inc. Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.


Quote


Last:$3.59
Change Percent: 1.7%
Open:$3.59
Close:$3.53
High:$3.71
Low:$3.59
Volume:7,789
Last Trade Date Time:03/04/2026 12:09:57 pm

Stock Data


Market Cap:$37,539,809
Float:4,939,449
Insiders Ownership:7.3%
Institutions:10
Short Percent:N/A
Industry:Biotechnology & Life Sciences
Sector:Healthcare
Website:https://www.pluri-biotech.com
Country:IL
City:Haifa

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


**MWN-AI FAQ is based on asking OpenAI questions about Pluri Inc. (NASDAQ: PLUR).

Link Market Wire News to Your X Account

Download The Market Wire News App

s